Tonix Pharmaceuticals, Inc.
Tonix Pharmaceuticals, Inc.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-09-25 | NCT07621237 | |
| Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) | Stress Disorders, Traumatic, Stress Disorders, Traumatic, Acute, acute stress disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-09-01 | NCT06636786 | |
| (TNX-1500) in Kidney Transplant Recipients | Immunosuppression; Immunosuppression After Kidney Transplantation; Kidney Transplant; Kidney Transplant Failure and Rejection | Not yet recruiting | Phase 2 | 2026-08-19 | NCT07204080 | |
| Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 2 | 2026-07-28 | NCT07730294 | |
| Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency | Diabetes Insipidus, Neurogenic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, anxiety disorder, brain disorder, central nervous system disorder, depressive disorder, diabetes insipidus, endocrine system disorder, hypopituitarism, hypothalamic disorder, kidney disorder, nervous system disorder, pituitary gland disorder, psychiatric disorder, urinary system disorder | Recruiting | Phase 1 | 2026-07-23 | NCT04789148 | |
| A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants | Open Label; Pharmakokinetic; Phase 1 | Active, not recruiting | Phase 1 | 2026-02-17 | NCT07413367 |